Yuan-Yi Zhao, Lin Xie, Ruo-Ying Wang, Ya Yan, Li-Li Liu
{"title":"<i>Treponema pallidum</i> Protein TpF1 Inhibits Migration by Impairing Actin Polymerization via Toll-Like Receptor 4/PI3K/AKT in Microglia.","authors":"Yuan-Yi Zhao, Lin Xie, Ruo-Ying Wang, Ya Yan, Li-Li Liu","doi":"10.1021/acsinfecdis.4c00868","DOIUrl":null,"url":null,"abstract":"<p><p><i>Treponema pallidum</i> induces a host immune response during central nervous system (CNS) invasion, prompting microglia to migrate to the site of injury, where they release effector molecules or phagocytose pathogens. However, the role of impaired microglial migration in the pathogenesis of <i>T. pallidum</i> infection remains poorly understood. In this study, we sought to explore the molecular mechanisms by which the <i>T. pallidum</i> protein TpF1 inhibits microglial migration. Microglial HMC3 cells were used to assess the effects of TpF1 on cellular migration and its impact on actin polymerization. Our findings demonstrate that TpF1 significantly reduces microglial migration in both horizontal and vertical directions. This effect correlates with a marked decrease in the filamentous actin (F-actin)/globular actin (G-actin) ratio, as confirmed by immunofluorescence analysis, which revealed a considerable reduction in F-actin levels. Moreover, TpF1 was found to suppress the expression of Toll-like receptor 4 (TLR4), phosphorylated PI3K (P-PI3K)/PI3K, phosphorylated AKT (P-AKT)/AKT, and Rac1. Inhibition of the TLR4/PI3K/AKT signaling pathway further impaired actin polymerization and migration. Collectively, our study identifies a novel mechanism by which TpF1 disrupts microglial migration via the TLR4/PI3K/AKT pathway, providing valuable insights into immune evasion strategies during <i>T. pallidum</i>-induced CNS infection.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":"11 5","pages":"1104-1113"},"PeriodicalIF":3.8000,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acsinfecdis.4c00868","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/24 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Treponema pallidum induces a host immune response during central nervous system (CNS) invasion, prompting microglia to migrate to the site of injury, where they release effector molecules or phagocytose pathogens. However, the role of impaired microglial migration in the pathogenesis of T. pallidum infection remains poorly understood. In this study, we sought to explore the molecular mechanisms by which the T. pallidum protein TpF1 inhibits microglial migration. Microglial HMC3 cells were used to assess the effects of TpF1 on cellular migration and its impact on actin polymerization. Our findings demonstrate that TpF1 significantly reduces microglial migration in both horizontal and vertical directions. This effect correlates with a marked decrease in the filamentous actin (F-actin)/globular actin (G-actin) ratio, as confirmed by immunofluorescence analysis, which revealed a considerable reduction in F-actin levels. Moreover, TpF1 was found to suppress the expression of Toll-like receptor 4 (TLR4), phosphorylated PI3K (P-PI3K)/PI3K, phosphorylated AKT (P-AKT)/AKT, and Rac1. Inhibition of the TLR4/PI3K/AKT signaling pathway further impaired actin polymerization and migration. Collectively, our study identifies a novel mechanism by which TpF1 disrupts microglial migration via the TLR4/PI3K/AKT pathway, providing valuable insights into immune evasion strategies during T. pallidum-induced CNS infection.
期刊介绍:
ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to:
* Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials.
* Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets.
* Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance.
* Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents.
* Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota.
* Small molecule vaccine adjuvants for infectious disease.
* Viral and bacterial biochemistry and molecular biology.